Systematic review of imiquimod for the treatment of external genital wart

International Journal of Pharmacology

Volumn 3, Issue 1, 2007, Pages 1-10

  Jaffary, F ^a,b,c   Musini, V ^c   Nilforoushzadeh, M A ^b   Bassett, K ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

External genital wart; Imiquimod; Systematic review

Indexed keywords

ALPHA2B INTERFERON; BLEOMYCIN; IMIQUIMOD; PLACEBO; PODOPHYLLIN; PODOPHYLLOTOXIN; RETINOID; TRICHLOROACETIC ACID;

APPLICATION SITE EDEMA; APPLICATION SITE ERYTHEMA; APPLICATION SITE EXCORIATION; APPLICATION SITE PAIN; APPLICATION SITE PRURITUS; APPLICATION SITE SCABBING; APPLICATION SITE SWELLING; CIRCUMCISION; CLINICAL TRIAL; COCHRANE LIBRARY; COLD TREATMENT; CONDYLOMA ACUMINATUM; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; DIABETIC COMA; DISEASE SEVERITY; DIZZINESS; DOSAGE SCHEDULE COMPARISON; DRUG CLEARANCE; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG WITHDRAWAL; ELECTROSURGERY; EROSION; FATIGUE; FLU LIKE SYNDROME; FOLLOW UP; HEADACHE; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INSOMNIA; LASER; LOCAL SKIN REACTION; LONG TERM CARE; META ANALYSIS; MORTALITY; MYALGIA; NAUSEA; PAGET SKIN DISEASE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; REVIEW; RHABDOMYOLYSIS; SKIN BURNING SENSATION; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; TREATMENT DURATION; UPPER RESPIRATORY TRACT INFECTION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VAGINA CANCER;

EID: 34248375215     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2007.1.10     Document Type: Review

References (26)

1. Aldara™ product monograph, 3m Pharmaceuticals, June 2004.
2. Arican, O., F. Guneri, K. Bilgic and A. Karaoglu, 2004. Topical imiquimod 5% cream in external anogenital warts: A randomized, double-blind, placebo-controlled study. J. Dermatol., 31:627-631.
3. Beutner, K., S. Spruance, A. Hougham, T. Fox, M. Owens and J. Douglas, 1998. Treatment of genital warts with an immune-response modifier (imiquimod). J. Am. Acad. Dermatol., 38: 230-239.
4. Coleman, N., H.D. Birley, A.M. Renton, N.F. Hanna, B.K. Ryait, M. Byrne, D. Taylor-Robinson and M.A. Stanley, 1994. Immunological events in regressing genital warts. Am. J. Clin. Pathol., 102: 768-774.
5. Daling, J.R., N.S. Weiss, T.G. Hislop, C. Maden, R.J. Coates, K.J. Sherman, R.L.M. Ashley, Beagrie, J.A. Ryan and L. Corey, 1987. Sexual practices, sexually transmitted diseases and the incidence of anal cancer. N. Engl. J. Med., 317: 973.
6. Edwards, L., A. Ferenczy, L. Eron, D. Baker, M. Owens, T. Fox, A. Hougham and K. Schmitt and the HPV Study Group, 1998. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch. Dermatol., 134: 25-30.
7. Ferenczy, A., 1998. Immune response modifiers: Iimiquimod. J. Ob. Gyn., 18: Supp 2; S76-78.
8. Fife, K.H., A. Ferenczy, J.M. Douglas, D.R. Jr. Brown, M. Smith and M.L. Owens, 2001. HPV Study Group. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day. Sex. Transmit. Dis., 28: 226-231.
9. Gilson, R.J, J.L. Shupack, A.E. Friedman-Kien, M.A. Conant, J.N. Weber, A.T. Nayagam, R.V. Swann, D.C. Pietig, M.H. Smith and M.L. Owens, 1999. A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients. Imiquimod Study Group AIDS., 13: 2397-404.
10. Gollnick, H., R. Barasso, U. Jappe, K. Ward, A. Eul, M. Carey-Yard and K. Milde, 2001. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int. J. STD. AIDS., 12: 22-28.
11. Habif, Clinical Dermatology, 4th Edn., 2004 Mosby, Inc. Genital Wart, pp: 336-342.
12. Hemmi, H., T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, K. Hoshino, T. Horiuchi, H. Tomizawa, K. Takeda and S. Akira, 2002. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol., 2: 196-200.
13. Hurwitz, D.J., L. Pincus and T.S. Kupper, 2003. Imiquimod: A topically applied link between innate and acquired immunity. Arch. Dermatol., 139: 1347-1350.
14. Koliopoulos, G., P. Martin-Hirsch, E. Paraskevaidis and M. Arbyn, 2005. HPV testing versus cervical cytology for screening for cancer of the uterine cervix (Protocol). The Cochrane Database of Systematic Reviews 2005; Vol. 1.
15. Macnab, J.C., S.A. Walkinshaw, J.W, Cordiner and J.B. Clements, 1986. Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. N. Engl. J. Med., 315: 1052.
16. Perry, C.M. and H.M. Lamb, 1999. Topical Imiquimod: A Review of its Use in Genital Warts. Drugs, 58: 375-390.
17. Sanclemente, G. and D.K. Gill, 2002. Human Papillomavirus molecular biology and pathogenesis. J. Eur. Acad. Dermatol. Venereol., 16: 231-240.
18. Sellors, J.W., T.L. Karwalajtys, J. Kaczorowski, J.B. Mahony, A. Lytwyn, S. Chong, J. Sparrow and A. Lorincz, 2003. Survey of HPV in Ontario Women Group. Incidence, clearance and predictors of human papillomavirus infection in women C.M.A.J., 168: 421-425.
19. Sellors, J.W., J.B. Mahony, J. Kaczorowski, A. Lytwyn, H. Bangura, S. Chong, A. Lorincz, D.M. Dalby, V. Janjusevic and J.L. Keller, 2000. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group C.M.A.J., 163: 503-508.
20. Sexually Transmitted Diseases Treatment Guidelines, 2002. Morbidity and Mortality Weekly Report. Recommendations and Reports 2002; 51:55 available at http://www.cdc.gov/std/treatment/rr5106.pdf
21. Stone, K.M., 1995. Human papillamovirus infection and general warts: Update on epidemiology and treatment. Clin. Infect. Dis., 20(Suppl 1): S91-97.
22. Syed, T., O.A. Ahmadpour, S.A. Ahmad and S.H. Ahmad, 1998. Management of female genital warts with an analog of imiquimod 2% in cream: A randomized, double-blind, placebo-controlled study. J. Dermatol., 25: 429-433.
23. Syed, T.A., S.M. Hadi, Z.A. Qureshi, S.M. Ali and M.S. Kwah, 2000. Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study. J. Infect., 41: 148-151.
24. Ting, P.T. and M.T. Dytoc, 2004. Therapy of external anogenital warts and molluscum contagiosum: A literature review. Dermatol. Ther., 17: 68-101.
25. Trofatter, K.F., A. Ferenzy and K.H. Fife, 2002. HPV Study Group, Increased frequency of dosing of imiquimod 5% in the treatment of external genital warts in women. Intl. J. Gyn. Ob., 76: 191-193
26. Tyring, S.K., I. Arany, M.A. Stanley, M.A. Tomai, R.L. Miller, M.H. Smith, D.J. McDermott and H.B. Slade, 1998. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J. Infect. Dis., 178: 551-555.